Shanghai Junshi Biosciences Co., Ltd. Class H (HK:1877) has released an update.
Shanghai Junshi Biosciences Co., Ltd. has announced a change in the implementation entity for its investment projects. The company raised over RMB 3.7 billion through the issuance of 70 million shares to target subscribers, with the funds now fully available. This strategic move aims to optimize their investment strategy and enhance project execution.
For further insights into HK:1877 stock, check out TipRanks’ Stock Analysis page.